Wealth Enhancement Advisory Services
AMRX icon

Wealth Enhancement Advisory Services’s Amneal Pharmaceuticals AMRX Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$316K Buy
59,123
+804
+1% +$11K ﹤0.01% 3158
2026
Q1 		$223K Buy
58,319
+41,872
+255% +$562K ﹤0.01% 3052
2025
Q4 		$225K Sell
16,447
-1,127
-6% -$12.9K ﹤0.01% 3177
2025
Q3 		$182K Buy
17,574
+4,204
+31% +$37.7K ﹤0.01% 3171
2025
Q2 		$113K Buy
+13,370
New +$101K ﹤0.01% 3121

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Wealth Enhancement Advisory Services's AMRX Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Amneal Pharmaceuticals (AMRX) stake by 1.4% in Q2 2026, buying an estimated $11K and bringing the position to 59,123 shares worth $316K. The position accounts for ﹤0.01% of the portfolio, ranked #3158.

Wealth Enhancement Advisory Services first reported a position in AMRX in Q2 2025 and has held it in 5 quarters since. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Wealth Enhancement Advisory Services held 59,123 shares of Amneal Pharmaceuticals worth $316K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 804 Amneal Pharmaceuticals shares in Q2 2026, an estimated $11K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3158 holding.
  • Wealth Enhancement Advisory Services first reported a position in Amneal Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.